7,05% | % de acciones controlado por personas con información privilegiada |
72,14% | % de acciones controlado por instituciones |
77,61% | % de capital flotante controlado por instituciones |
127 | Número de participaciones de instituciones |
Accionista | Acciones | Fecha de notificación | % fuera | Valor |
---|---|---|---|---|
Decheng Capital LLC | 5.458.810 | 30 mar 2024 | 8,19% | 168.185.933 |
TCG Crossover Management, LLC | 3.570.206 | 30 mar 2024 | 5,36% | 109.998.044 |
Blackrock Inc. | 2.518.550 | 30 mar 2024 | 3,78% | 77.596.524 |
Vanguard Group Inc | 2.225.018 | 30 mar 2024 | 3,34% | 68.552.803 |
BVF Inc. | 1.884.191 | 30 mar 2024 | 2,83% | 58.051.923 |
Janus Henderson Group PLC | 1.521.432 | 30 mar 2024 | 2,28% | 46.875.319 |
Avidity Partners Management, LP | 1.454.765 | 30 mar 2024 | 2,18% | 44.821.308 |
RA Capital Management, L.P. | 1.397.433 | 30 mar 2024 | 2,10% | 43.054.909 |
Perceptive Advisors Llc | 1.304.105 | 30 mar 2024 | 1,96% | 40.179.474 |
Braidwell LP | 1.130.235 | 30 mar 2024 | 1,70% | 34.822.539 |
Accionista | Acciones | Fecha de notificación | % fuera | Valor |
---|---|---|---|---|
iShares Russell 2000 ETF | 568.675 | 30 mar 2024 | 0,85% | 17.520.876 |
AB Cap Fd.-AB Small Cap Growth Port | 517.440 | 30 mar 2024 | 0,78% | 15.942.326 |
Blackrock Funds-Health Sciences Opportunity Portfolio | 297.007 | 28 feb 2024 | 0,45% | 9.150.785 |
Franklin Strategic Series-Franklin Small-Mid Cap Growth | 287.600 | 30 ene 2024 | 0,43% | 8.860.955 |
Franklin Strategic Series-Franklin Small Cap Growth Fund | 197.800 | 30 ene 2024 | 0,30% | 6.094.217 |
MFS New Discovery Fund | 171.101 | 28 feb 2024 | 0,26% | 5.271.621 |
Principal Small Cap Growth Fd I | 120.053 | 30 ene 2024 | 0,18% | 3.698.832 |
iShares Russell 2000 Value ETF | 121.290 | 30 mar 2024 | 0,18% | 3.736.944 |
Fidelity Extended Market Index Fund | 116.296 | 30 mar 2024 | 0,17% | 3.583.079 |
Franklin Strategic Series-Franklin Biotechnology Discove | 101.600 | 30 ene 2024 | 0,15% | 3.130.295 |